Works matching IS 03065251 AND DT 1982 AND VI 13 AND IP 6
1
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 811, doi. 10.1111/j.1365-2125.1982.tb01871.x
- Forsyth, JS;
- Moreland, TA;
- Rylance, GW
- Article
2
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 872, doi. 10.1111/j.1365-2125.1982.tb01882.x
- Elvin, AT;
- Axelson, JE;
- Lalka, D
- Article
3
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 761, doi. 10.1111/j.1365-2125.1982.tb01864.x
- Article
4
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 835, doi. 10.1111/j.1365-2125.1982.tb01875.x
- Peden, NR;
- Isles, TE;
- Stevenson, IH;
- Crooks, J
- Article
5
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 795, doi. 10.1111/j.1365-2125.1982.tb01868.x
- Gundert-Remy, U;
- Frohnapfel, F;
- Jourdan, W;
- Weber, E;
- Stiehl, A
- Article
6
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 859, doi. 10.1111/j.1365-2125.1982.tb01879.x
- MacGregor, GA;
- Banks, RA;
- Markandu, ND;
- Roulston, J
- Article
7
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 807, doi. 10.1111/j.1365-2125.1982.tb01870.x
- Article
8
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 871, doi. 10.1111/j.1365-2125.1982.tb01881.x
- Doyle, VM;
- O'Malley, K;
- Kelly, JG
- Article
9
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 829, doi. 10.1111/j.1365-2125.1982.tb01874.x
- Adjepon-Yamoah, KK;
- Edwards, G;
- Breckenridge, AM;
- Orme, ML;
- Ward, SA
- Article
10
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 791, doi. 10.1111/j.1365-2125.1982.tb01867.x
- Wang, C;
- Lai, CL;
- Lam, KC;
- Yeung, KK
- Article
11
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 855, doi. 10.1111/j.1365-2125.1982.tb01878.x
- Atkinson, AB;
- Cumming, AM;
- Brown, JJ;
- Fraser, R;
- Leckie, B;
- Lever, AF;
- Morton, JJ;
- Robertson, JI
- Article
12
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 865, doi. 10.1111/j.1365-2125.1982.tb01880.x
- Seideman, P;
- Grahnen, A;
- Haglund, K;
- Lindstrom, B;
- Bahr, C
- Article
13
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 821, doi. 10.1111/j.1365-2125.1982.tb01873.x
- Harron, DW;
- Arndts, D;
- Shanks, RG
- Article
14
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 785, doi. 10.1111/j.1365-2125.1982.tb01866.x
- Little, PJ;
- Jennings, GL;
- Skews, H;
- Bobik, A
- Article
15
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 847, doi. 10.1111/j.1365-2125.1982.tb01877.x
- Wright, JM;
- Orozco-Gonzalez, M;
- Polak, G;
- Dollery, CT
- Article
16
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 817, doi. 10.1111/j.1365-2125.1982.tb01872.x
- Daneshmend, TK;
- Roberts, CJ
- Article
17
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 775, doi. 10.1111/j.1365-2125.1982.tb01865.x
- Saintonge, Chaput de DM;
- Vere, DW
- Article
18
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 841, doi. 10.1111/j.1365-2125.1982.tb01876.x
- Article
19
- British Journal of Clinical Pharmacology, 1982, v. 13, n. 6, p. 803, doi. 10.1111/j.1365-2125.1982.tb01869.x
- Hurlow, RA;
- Aukland, A;
- Hardman, J;
- Whittington, JR
- Article